Viking Global Investors’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,564,173
Closed -$15.9M 99
2023
Q4
$15.9M Hold
3,564,173
0.06% 75
2023
Q3
$5.31M Hold
3,564,173
0.02% 78
2023
Q2
$8.13M Hold
3,564,173
0.03% 84
2023
Q1
$6.95M Hold
3,564,173
0.03% 78
2022
Q4
$5.85M Hold
3,564,173
0.03% 74
2022
Q3
$7.09M Hold
3,564,173
0.03% 87
2022
Q2
$7.7M Buy
3,564,173
+2,064,173
+138% +$7.01M 0.04% 82
2022
Q1
$5.57M Hold
1,500,000
0.02% 89
2021
Q4
$9.24M Buy
+1,500,000
New +$17.1M 0.03% 105

Other funds holding LIAN

Viking Global Investors's LIAN Position: Q1 2024 in Review

Viking Global Investors sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 3,564,173 shares — an estimated $15.9M sold.

Viking Global Investors first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $15.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

  • Viking Global Investors reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Viking Global Investors sold 3,564,173 LianBio American Depositary Shares shares in Q1 2024, an estimated $15.9M.
  • Viking Global Investors first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Viking Global Investors's LianBio American Depositary Shares position peaked at $15.9M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Viking Global Investors's 13F filing for Q1 2024, filed 15 May 2024.